{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:58Z","timestamp":1761895618734,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.biopha.2013.01.010","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T02:08:09Z","timestamp":1361239689000},"page":"277-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer"],"prefix":"10.1016","volume":"67","author":[{"given":"Regina","family":"Arantes-Rodrigues","sequence":"first","affiliation":[]},{"given":"Ros\u00e1rio","family":"Pinto-Leite","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Neuparth","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Gaiv\u00e3o","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"L\u00facio","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Aura","family":"Cola\u00e7o","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2013.01.010_bib0005","first-page":"400","article-title":"Chronic inflammation and cancer: the role of the mitochondria","volume":"25","author":"Kamp","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.biopha.2013.01.010_bib0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biopha.2013.01.010_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/1-4020-5688-5_4","article-title":"Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer","volume":"42","author":"Harris","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.biopha.2013.01.010_bib0020","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3390\/ph3082495","article-title":"Non-steroidal anti-inflammatory drugs in the carcinogenesis of the gastrointestinal tract","volume":"3","author":"Compare","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2013.01.010_bib0025","doi-asserted-by":"crossref","first-page":"215158","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.biopha.2013.01.010_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1939-1676.2011.00836.x","article-title":"Inflammation and cancer: a comparative view","volume":"26","author":"Morrison","year":"2012","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.biopha.2013.01.010_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cvsm.2012.01.003","article-title":"Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats","volume":"42","author":"Khan","year":"2012","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.biopha.2013.01.010_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2478\/v10007-010-0020-0","article-title":"Formulation of meloxicam gel for topical application: in vitro and in vivo evaluation","volume":"60","author":"Bachhav","year":"2010","journal-title":"Acta Pharm"},{"key":"10.1016\/j.biopha.2013.01.010_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.biopha.2013.01.010_bib0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/bgh110","article-title":"Cyclooxygenase 2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice","volume":"25","author":"Kern","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2013.01.010_bib0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2009.11.036","article-title":"Effective antiproliferative effect of meloxicam on prostate cancer-cells: development of a new controlled release system","volume":"387","author":"Montejo","year":"2010","journal-title":"Int J Pharma"},{"issue":"4","key":"10.1016\/j.biopha.2013.01.010_bib0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupr\u00eat","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.biopha.2013.01.010_bib0065","article-title":"In vivo and in vitro effects of RAD001 on urinary bladder cancer","author":"Vasconcelos-N\u00f3brega","year":"2011","journal-title":"Urol Oncol"},{"issue":"13-15","key":"10.1016\/j.biopha.2013.01.010_bib0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/15287394.2012.690325","article-title":"Everolimus enhances gemcitabine-induced cytotoxicity in urinary bladder cancer-cell lines","volume":"75","author":"Pinto-Leite","year":"2012","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.biopha.2013.01.010_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The comet assay for DNA damage and repair: principles applications, and limitations","volume":"26","author":"Collins","year":"2004","journal-title":"Mol Biotechnol"},{"issue":"12","key":"10.1016\/j.biopha.2013.01.010_bib0080","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/carcin\/19.12.2195","article-title":"Meloxicam inhibits the growth of colorectal cancer-cells","volume":"19","author":"Goldman","year":"1998","journal-title":"Carcinogenesis"},{"year":"2004","series-title":"Classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs","author":"Eble","key":"10.1016\/j.biopha.2013.01.010_bib0085"},{"issue":"2 Suppl.","key":"10.1016\/j.biopha.2013.01.010_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/107327480200902S04","article-title":"Celecoxib: a specific COX-2 inhibitor with anticancer properties","volume":"9","author":"Koki","year":"2002","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.biopha.2013.01.010_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2885.2006.00704.x","article-title":"In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells","volume":"29","author":"Wolfesberger","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.biopha.2013.01.010_bib0100","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1440-1746.2006.04366.x","article-title":"Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells","volume":"21","author":"Li","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.biopha.2013.01.010_bib0105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.22854","article-title":"Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers","volume":"110","author":"Xin","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2013.01.010_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11060-007-9385-4","article-title":"Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells","volume":"85","author":"Bijnsdorp","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.biopha.2013.01.010_bib0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(02)03535-4","article-title":"Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells","volume":"531","author":"Yamazaki","year":"2002","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.biopha.2013.01.010_bib0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1464-410X.2006.06053.x","article-title":"Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis","volume":"97","author":"Hattori","year":"2006","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.biopha.2013.01.010_bib0125","first-page":"23","article-title":"Rat and mouse urothelial carcinogenesis","volume":"2","author":"Oliveira","year":"2008","journal-title":"Exp Pathol Health Sci"},{"key":"10.1016\/j.biopha.2013.01.010_bib0130","first-page":"380937","article-title":"Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model","author":"Sereno","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.biopha.2013.01.010_bib0135","first-page":"3028","article-title":"Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine","volume":"58","author":"Okajima","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2013.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/carcin\/14.7.1487","article-title":"Chemoprevention of OH-BBN-induced urinary bladder cancer in mice by piroxicam","volume":"14","author":"Moon","year":"1993","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2013.01.010_bib0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.urolonc.2009.01.016","article-title":"Prevention of urinary urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor","volume":"28","author":"D\u2019Arca","year":"2010","journal-title":"Urol Oncol"},{"issue":"17","key":"10.1016\/j.biopha.2013.01.010_bib0150","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.4161\/cbt.8.17.9199","article-title":"Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis","volume":"8","author":"Parada","year":"2009","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10.1016\/j.biopha.2013.01.010_bib0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-alpha in cancer treatment: molecular insights, antitumour effects, and clinical utility","volume":"11","author":"van Horssen","year":"2006","journal-title":"Oncologist"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:51:51Z","timestamp":1760093511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332213000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0753332213000139"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2013.01.010","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2013.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}